Mayo Clinic IBD Biobank
NCT03756649 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-02-17
Summary
Researchers are collecting and storing blood, stool, and urine samples and medical information to better understand Inflammatory Bowel Disease (IBD) to improve disease outcome.
Conditions
- Inflammatory Bowel Diseases
Interventions
- PROCEDURE
-
Blood Draw
50 ml will be collected
- PROCEDURE
-
Urine Collection
50 ml will be collected
- PROCEDURE
-
Stool Collection
Three 25 ml tubes will be collected
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Konstantinos N. Lazaridis, MD · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-11-01
- Primary Completion
- 2065-12-31
- Completion
- 2065-12-31
Countries
- United States
Study Locations
More Related Trials
-
IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD.
NCT02130349 ·Status: UNKNOWN
-
Value of Fecal Calprotectin
NCT00577928 ·Status: COMPLETED
-
San Raffaele IBD Biobank
NCT06071572 ·Status: RECRUITING
-
Biobank - Investigating the Gut Microbiota, Genetics, Epigenetics and Metabolites
NCT03855657 ·Status: RECRUITING
-
Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease
NCT02073526 ·Status: COMPLETED
-
Manitoba Inflammatory Bowel Disease Cohort Study
NCT03262649 ·Status: COMPLETED
-
Inflammatory Bowel Disease(IBD), Treatment Response
NCT05350644 ·Status: TERMINATED
-
Assessment of Non-invasive Tools for Detecting Active Inflammatory Bowel Disease
NCT06722456 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA
-
Biomarkers in Inflammatory Bowel Diseases
NCT02612103 ·Status: COMPLETED
-
Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling
NCT01666717 ·Status: COMPLETED
-
Genome Analysis Across Populations in Inflammatory Bowel Disease
NCT06042387 ·Status: RECRUITING
-
Predictors of Prognosis in IBD Patients
NCT05653011 ·Status: RECRUITING
-
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
NCT03251118 ·Status: ACTIVE_NOT_RECRUITING
-
The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control Group
NCT03778918 ·Status: UNKNOWN
-
A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)
NCT05596422 ·Status: COMPLETED
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
Registry and Biorepository for IBD in Central Texas
NCT04617184 ·Status: RECRUITING
-
Telomere Repair Gene Mutation in Inflammatory Bowel Disease
NCT00353639 ·Status: COMPLETED
-
Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
NCT03264690 ·Status: COMPLETED
-
Characterization of Human Intestinal Macrophages in Metabolic Disease
NCT03796000 ·Status: COMPLETED
-
Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease
NCT06548399 ·Status: RECRUITING
-
Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)
NCT01289366 ·Status: COMPLETED
-
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
NCT00586599 ·Status: COMPLETED ·Phase: NA
-
The Gut Virome as a Trigger for IBD: From Metagenomics to Pathogenesis
NCT05906680 ·Status: UNKNOWN